Literature DB >> 25435253

Modified 2,4-diaminopyrimidine-based dihydrofolate reductase inhibitors as potential drug scaffolds against Bacillus anthracis.

Baskar Nammalwar1, Christina R Bourne2, Nancy Wakeham2, Philip C Bourne2, Esther W Barrow2, N Prasad Muddala1, Richard A Bunce3, K Darrell Berlin1, William W Barrow2.   

Abstract

The current Letter describes the synthesis and biological evaluation of dihydrophthalazine-appended n class="Chemical">2,4-diaminopyrimidine (DAP) inhibitors (1) oxidized at the methylene bridge linking the DAP ring to the central aromatic ring and (2) modified at the central ring ether groups. Structures 4a-b incorporating an oxidized methylene bridge showed a decrease in activity, while slightly larger alkyl groups (CH2CH3 vs CH3) on the central ring oxygen atoms (R(2) and R(3)) had a minimal impact on the inhibition. Comparison of the potency data for previously reported RAB1 and BN-53 with the most potent of the new derivatives (19 b and 20a-b) showed similar values for inhibition of cellular growth and direct enzymatic inhibition (MICs 0.5-2 μg/mL). Compounds 29-34 with larger ester and ether groups containing substituted aromatic rings at R(3) exhibited slightly reduced activity (MICs 2-16 μg/mL). One explanation for this attenuated activity could be encroachment of the extended R(3) into the neighboring NADPH co-factor. These results indicate that modest additions to the central ring oxygen atoms are well tolerated, while larger modifications have the potential to act as dual-site inhibitors of dihydrofolate reductase (DHFR).
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antibiotics; Antifolates; Antimicrobial agents; Bacillus anthracis inhibition; Dihydrofolate reductase

Mesh:

Substances:

Year:  2014        PMID: 25435253      PMCID: PMC4278362          DOI: 10.1016/j.bmc.2014.11.009

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  23 in total

1.  Structure-based design of new DHFR-based antibacterial agents: 7-aryl-2,4-diaminoquinazolines.

Authors:  Xiaoming Li; Mark Hilgers; Mark Cunningham; Zhiyong Chen; Michael Trzoss; Junhu Zhang; Lucy Kohnen; Thanh Lam; Chris Creighton; Kedar G C; Kirk Nelson; Bryan Kwan; Mark Stidham; Vickie Brown-Driver; Karen J Shaw; John Finn
Journal:  Bioorg Med Chem Lett       Date:  2011-07-23       Impact factor: 2.823

2.  Bisubstrate analog inhibitors of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase: new lead exhibits a distinct binding mode.

Authors:  Genbin Shi; Gary Shaw; Yue Li; Yan Wu; Honggao Yan; Xinhua Ji
Journal:  Bioorg Med Chem       Date:  2012-06-06       Impact factor: 3.641

3.  Structure-activity relationship for enantiomers of potent inhibitors of B. anthracis dihydrofolate reductase.

Authors:  Christina R Bourne; Nancy Wakeham; Baskar Nammalwar; Vladimir Tseitin; Philip C Bourne; Esther W Barrow; Shankari Mylvaganam; Kal Ramnarayan; Richard A Bunce; K Darrell Berlin; William W Barrow
Journal:  Biochim Biophys Acta       Date:  2012-09-20

4.  Catalysis and sulfa drug resistance in dihydropteroate synthase.

Authors:  Mi-Kyung Yun; Yinan Wu; Zhenmei Li; Ying Zhao; M Brett Waddell; Antonio M Ferreira; Richard E Lee; Donald Bashford; Stephen W White
Journal:  Science       Date:  2012-03-02       Impact factor: 47.728

5.  Inhibition of bacterial dihydrofolate reductase by 6-alkyl-2,4-diaminopyrimidines.

Authors:  Baskar Nammalwar; Christina R Bourne; Richard A Bunce; Nancy Wakeham; Philip C Bourne; Kal Ramnarayan; Shankari Mylvaganam; K Darrell Berlin; Esther W Barrow; William W Barrow
Journal:  ChemMedChem       Date:  2012-08-28       Impact factor: 3.466

6.  In vitro efficacy of new antifolates against trimethoprim-resistant Bacillus anthracis.

Authors:  Esther W Barrow; Jürg Dreier; Stefan Reinelt; Philip C Bourne; William W Barrow
Journal:  Antimicrob Agents Chemother       Date:  2007-09-17       Impact factor: 5.191

7.  Antistaphylococcal activity of dihydrophthalazine antifolates, a family of novel antibacterial drugs.

Authors:  Catherine Clark; Lois M Ednie; Gengrong Lin; Kathy Smith; Klaudia Kosowska-Shick; Pamela McGhee; Bonifacio Dewasse; Linda Beachel; Patrick Caspers; Bérangère Gaucher; Gürkan Mert; Stuart Shapiro; Peter C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  2009-02-02       Impact factor: 5.191

8.  Increased hydrophobic interactions of iclaprim with Staphylococcus aureus dihydrofolate reductase are responsible for the increase in affinity and antibacterial activity.

Authors:  Christian Oefner; Monica Bandera; Andreas Haldimann; Heike Laue; Henk Schulz; Seema Mukhija; Sandro Parisi; Laurent Weiss; Sergio Lociuro; Glenn E Dale
Journal:  J Antimicrob Chemother       Date:  2009-02-11       Impact factor: 5.790

9.  In vitro and in vivo properties of dihydrophthalazine antifolates, a novel family of antibacterial drugs.

Authors:  Patrick Caspers; Luc Bury; Bérangère Gaucher; Jutta Heim; Stuart Shapiro; Sibylle Siegrist; Anne Schmitt-Hoffmann; Laure Thenoz; Heinrich Urwyler
Journal:  Antimicrob Agents Chemother       Date:  2009-06-22       Impact factor: 5.191

10.  Synthesis and biological evaluation of 2,4-diaminopyrimidine-based antifolate drugs against Bacillus anthracis.

Authors:  Baskar Nammalwar; N Prasad Muddala; Christina R Bourne; Mary Henry; Philip C Bourne; Richard A Bunce; Esther W Barrow; K Darrell Berlin; William W Barrow
Journal:  Molecules       Date:  2014-03-17       Impact factor: 4.411

View more
  5 in total

Review 1.  Chemical space of Escherichia coli dihydrofolate reductase inhibitors: New approaches for discovering novel drugs for old bugs.

Authors:  Bharath Srinivasan; Sam Tonddast-Navaei; Ambrish Roy; Hongyi Zhou; Jeffrey Skolnick
Journal:  Med Res Rev       Date:  2018-09-07       Impact factor: 12.944

2.  Evaluation of New Dihydrophthalazine-Appended 2,4-Diaminopyrimidines against Bacillus anthracis: Improved Syntheses Using a New Pincer Complex.

Authors:  Nagendra Prasad Muddala; Baskar Nammalwar; Subhashini Selvaraju; Christina R Bourne; Mary Henry; Richard A Bunce; K Darrell Berlin; Esther W Barrow; William W Barrow
Journal:  Molecules       Date:  2015-04-21       Impact factor: 4.411

Review 3.  Trimethoprim and other nonclassical antifolates an excellent template for searching modifications of dihydrofolate reductase enzyme inhibitors.

Authors:  Agnieszka Wróbel; Karolina Arciszewska; Dawid Maliszewski; Danuta Drozdowska
Journal:  J Antibiot (Tokyo)       Date:  2019-10-02       Impact factor: 2.649

4.  Dihydrofolate Reductase Inhibitors: The Pharmacophore as a Guide for Co-Crystal Screening.

Authors:  João A Baptista; Mário T S Rosado; Ricardo A E Castro; António O L Évora; Teresa M R Maria; Manuela Ramos Silva; João Canotilho; M Ermelinda S Eusébio
Journal:  Molecules       Date:  2021-11-06       Impact factor: 4.411

5.  Trimethoprim: An Old Antibacterial Drug as a Template to Search for New Targets. Synthesis, Biological Activity and Molecular Modeling Study of Novel Trimethoprim Analogs.

Authors:  Agnieszka Wróbel; Dawid Maliszewski; Maciej Baradyn; Danuta Drozdowska
Journal:  Molecules       Date:  2019-12-27       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.